Internal Medicine, Rheumatology · Anaheim, CA
NPI
1427125442
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
441 N Lakeview Ave
Anaheim, CA, 92807
Phone (888) 988-2800
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
2,283 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Swati Medhekar prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 330 prescriptions and refills. In total Swati Medhekar wrote 2,283 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxychloroquine Sulfate Generic | 330 | 977 | 119 | $9,060 |
| Methotrexate Methotrexate Sodium | 311 | 621 | 79 | $4,557 |
| Prednisone Generic | 261 | 488 | 91 | $2,977 |
| Leflunomide Generic | 187 | 384 | 47 | $4,332 |
| Enbrel Sureclick Etanercept | 145 | 145 | 21 | $708K |
| Rasuvo Methotrexate/Pf | 123 | 148 | 17 | $58K |
| Alendronate Sodium Generic | 120 | 331 | 38 | $1,173 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 91 | 112 | 25 | $94K |
| Mycophenolate Mofetil Generic | 70 | 149 | 21 | $7,163 |
| Enbrel Etanercept | 65 | 65 | Under 11 | $316K |
| Meloxicam Generic | 57 | 91 | 23 | $402 |
| Allopurinol Generic | 48 | 155 | 18 | $565 |
| Colchicine Generic | 38 | 59 | 14 | $626 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 32 | 42 | Under 11 | $132K |
| Amlodipine Besylate Generic | 32 | 94 | 12 | $402 |
Brand drugs: 603 claims; generic drugs: 1,680 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Swati Medhekar were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.